Role of exercise evaluation in restrictive lung disease: New insights between March 2001 and February 2003

Current Opinion in Pulmonary Medicine

Volumn 9, Issue 5, 2003, Pages 408-410

  Mascolo, Maria C ^a   Truwit, Jonathon Dean ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

6 minute walk; Exercise; Exercise testing; Restrictive lung disease

Indexed keywords

CARDIOPULMONARY INSUFFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DYSPNEA; EVALUATION; EXERCISE; EXERCISE TEST; HUMAN; HYPOXEMIA; INTENSIVE CARE; LUNG BIOPSY; LUNG DISEASE; LUNG FUNCTION TEST; MALE; OUTCOMES RESEARCH; OXIMETRY; OXYGEN THERAPY; PHYSICAL EXAMINATION; PREDICTION; RESTRICTIVE LUNG DISEASE; REVIEW; RISK ASSESSMENT; SARCOIDOSIS; SPIROMETRY; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; WALKING;

AIRCRAFT; EXERCISE TEST; HUMANS; LUNG DISEASES, OBSTRUCTIVE; SARCOIDOSIS, PULMONARY;

EID: 0042237858     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200309000-00012     Document Type: Review

References (11)

1. Blackie SP, Reggiani JF, Fairbarn MS, et al.: Improved analysis of breathing in exercise in restrictive ventilatory disease. Am Rev Resp Dis 1989, 139:A595.
2. Keogh BA, Lakatos E, Price D, et al.: Importance of lower respiratory tract in oxygen transfer: exercise testing in patients with interstitial and destructive lung disease. Am Rev Resp Dis 1984, 129:S76-S80.
3. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003, 167:211-277. This is a comprehensive update reviewing cardiopulmonary exercise testing-indications, testing, and interpretation - with guidelines set forth by the American Thoracic Society and the American College of Chest Physicians.
4. Agusti AG, Roca J, Gea J, et al.: Mechanisms of gas exchange impairment inidiopathic pulmonary fibrosis. Am Rev Resp Dis 1991, 143:219-225.
5. Nordenfelt I, Svensson G. The transfer factor (diffusing capacity) as a predictor of hypoxemia during exercise in restrictive and chronic obstructive pulmonary disease. Clin Physiol 1987, 7:423-430.
6. NHBLI workshop summary: respiratory muscle fatigue: report of the Respiratory Muscle Fatigue Workshop Group. Am Rev Resp Dis 1990, 142:474-480.
7. Bye PTB, Anderson SD, Woolcock AJ, et al.: Bicycle endurance performances of patients with interstitial lung disease breathing air and oxygen. Am Rev Resp Dis 1982, 126:1005-1012.
8. Medinger AE, Khouri S, Rohatgi P. Sarcoidosis: the value of exercise testing. Chest 2001, 120:93-101.
9. Delobbe A, Perrault H, Maitre J, et al.: Impaired exercise response in sarcoid patients with normal pulmonary function. Sarcoidosis Vasc Diffuse Lung Dis 2002, 19:148-153. Formal exercise testing may be a more sensitive indicator of abnormal pulmonary function than pulmonary function tests in patients with sarcoidosis.
10. Christensen CC, Ryg MS, et al.: Effect of hypoxia on blood gases in patients with restrictive lung disease. Eur Respir J 2002, 20:300-305.
11. Herridge MS, Canadian Critical Care Trials Group. Once-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003, 348:683-693. Survivors of acute respiratory distress syndrome have neuromuscular abnormalities as measured by the 6-minute walk at least 1 year after their illness. This is the first study following patients with acute respiratory distress syndrome as long as 1 year after discharge.